Matthew Gubens

Matthew Gubens, MD, MS, FASCO is a Professor of Medicine at the University of California San Francisco (UCSF), specializing in thoracic medical oncology. He serves as Medical Director of Thoracic Medical Oncology and Chair of the UCSF Cancer Center Protocol Review and Monitoring Committee, overseeing clinical cancer research. Dr. Gubens is actively involved in guideline development as Immediate Past Chair of the ASCO Evidence Based Medicine Committee, co-chair of the ASCO Thoracic Guideline Advisory Group, and member of National Comprehensive Cancer Network panels for non-small cell lung cancer, mesothelioma, and thymic malignancies. He also contributes to the Association of Northern California Oncologists as a Board member.

• Education:
  • BA in Ethics, Politics, and Economics from Yale University (1997)
  • MS in Health Policy and Management from Harvard School of Public Health (2000)
  • MD from Stanford University School of Medicine (2005)
  • Internal Medicine Residency at UCSF School of Medicine (2008)
  • Medical Oncology Fellowship at Stanford School of Medicine (2011)

His research focuses on thoracic oncology, with significant contributions to lung cancer, mesothelioma, and thymic malignancies through clinical trials, guideline development, and biomarker studies. Recent publications address multidisciplinary cancer care, frailty assessment in older adults, and genetic predictors of immunotherapy toxicity.

Dr. Gubens participates in several national committees and guideline panels, including NCCN and American Radium Society, focusing on optimizing treatment protocols and managing therapy-related complications.